EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Regulatory Effects of Zhenxin Formula in Treating Doxorubicin-Induced Heart Failure: Network Pharmacology and Animal Experimental Verification

Qiong Wu iD, Hao Wang, You Hua Wang, Jun Du, Bo Li, Xiao-Na Gan, Chen-Yang Liu, Jing Liang, Chang Liu, Min Cao

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s513643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Qiong Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Doxorubicin, Network Pharmacology, Drugs, Chinese Herbal, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinNetwork PharmacologyDrugs, Chinese HerbalHeart FailureAnimalsRatsDisease Models, AnimalMaleRats, Sprague-DawleyProtein Interaction MapsApoptosisSignal TransductionMice

Stichwörter der Autor:innen

PI3K/PDK1/AKT/FOXO1 signaling pathwayZhenxin Formulaheart failurenetwork pharmacologyphospho-antibody array

Substanzen

DoxorubicinDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Cardiology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Department of Emergency, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Nutrilite Health Institute, Amway (China) R&D Center, Shanghai, People's Republic of China.

ORCID-Profile: Qiong Wu

Zitieren

APA

Wu, Q., Wang, H., Wang, Y. H., Du, J., Li, B., Gan, X. N., Liu, C. Y., Liang, J., Liu, C., & Cao, M. (2025). Regulatory Effects of Zhenxin Formula in Treating Doxorubicin-Induced Heart Failure: Network Pharmacology and Animal Experimental Verification. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s513643

Vancouver

Wu Q, Wang H, Wang YH, Du J, Li B, Gan XN, et al. Regulatory Effects of Zhenxin Formula in Treating Doxorubicin-Induced Heart Failure: Network Pharmacology and Animal Experimental Verification. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s513643

BibTeX
@article{Wu2025,
  author = {Wu, Qiong and Wang, Hao and Wang, You Hua and Du, Jun and Li, Bo and Gan, Xiao-Na and Liu, Chen-Yang and Liang, Jing and Liu, Chang and Cao, Min},
  title = {Regulatory Effects of Zhenxin Formula in Treating Doxorubicin-Induced Heart Failure: Network Pharmacology and Animal Experimental Verification},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s513643}
}
Kostenlos starten →